2683 Results

People

  1. Chi
    Chi
  2. Barakat
    Barakat
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. Fong
    Fong
  6. Vickers
    Vickers
  7. Eastham
    Eastham
  8. Ladanyi
    Ladanyi
  9. Reuter
    Reuter
  10. Hudis
    Hudis

Groups

  1. Department of Medicine (784)
  2. Surgery (698)
  3. GSK Faculty (533)
  4. Sloan Kettering Institute Faculty (480)
  5. Solid Tumor Oncology Division (413)
  6. Survivorship Research (335)
  7. Population Sciences Research Program (261)
  8. Department of Pathology and Laboratory Medicine (244)
  9. Epidemiology and Biostatistics (239)
  10. Center for Hematologic Malignancies (237)
  1. "2009"
Formats
  1. Journal Article (1884)
  2. Meeting Abstract (566)
  3. Book Section (195)
  4. Conference Paper (22)
  5. Book Whole (16)
Groups
  1. Department of Medicine (784)
  2. Surgery (698)
  3. GSK Faculty (533)
  4. Sloan Kettering Institute Faculty (480)
  5. Solid Tumor Oncology Division (413)
  6. Survivorship Research (335)

More Groups

People
  1. Dennis Chi (53)
  2. Richard Barakat (51)
  3. Peter Scardino (47)
  4. Nadeem Abu-Rustum (44)
  5. Valerie Rusch (44)
  6. Yuman Fong (41)

More People

Years
  1. 2009 (2683)
Publications
  1. Journal of Clinical Oncology (219)
  2. Cancer Research (84)
  3. Blood (82)
  4. Gynecologic Oncology (64)
  5. Cancer Rehabilitation: Principles and Practice. 1st ed (51)
  6. Journal of Thoracic Oncology (44)

More Publications

Publishers
  1. Elsevier Inc. (297)
  2. American Society of Clinical Oncology (222)
  3. Elsevier Science, Inc. (164)
  4. Lippincott Williams & Wilkins (144)
  5. American Association for Cancer Research (143)
  6. Springer (137)

More Publishers

Results (2683)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated safety findings with tesetaxel, an orally administered taxane, in patients (pts) with gastric, colon, breast, and nonsmall cell lung cancer: Phase II results
    Meeting Abstract

    Novick, S. C.; Wu, J.; Ilson, D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Late mortality and morbidity of patients with Hodgkin lymphoma treated in adulthood
    Meeting Abstract

    Matasar, M. J.; McCallen, L. N.; Riedel, E. R.; Ford, J. S.; Oeffinger, K. C.; Straus, D. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of systemic sorafenib in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma
    Meeting Abstract

    McMahon, N.; Beasley, G. M.; Sanders, G.; Augustine, C.; Padussis, J.; Coleman, A.; Selim, M. A.; Peterson, B.; Brady, M. S.; Tyler, D. S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Effects of vascular endothelial growth factor (VEGF) signaling inhibition on human erythropoiesis
    Meeting Abstract

    Maitland, M. L.; Kasza, K. E.; Snider, K. L.; Sit, L.; Cohen, E. E.; Seiwert, T. Y.; Karrison, T.; Ratain, M. J.; Vokes, E. E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Impact of older age on the efficacy of newer adjuvant therapies in > 12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT Database
    Meeting Abstract

    McCleary, N. A. J.; Meyerhardt, J.; Green, E.; Yothers, G.; de Gramont, A.; Van Cutsem, E.; O'Connell, M.; Twelves, C.; Saltz, L.; Sargent, D.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A long-term open-label extension study examining the steroid-sparing effects of corticorelin acetate in patients with cerebral tumors
    Meeting Abstract

    Mechtler, L.; Wong, E. T.; Hormigo, A.; Pannullo, S.; Hines, V.; Milsted, R.; O'Connor, P. C.; Ryan, R. P.; Recht, L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of pemetrexed (P) and gemcitabine (G) in patients with advanced head and neck cancer (SCCHN)
    Meeting Abstract

    Mehra, R.; Sherman, E.; Ruth, K.; Litwin, S.; Sylvester, J.; Tuttle, H.; Burtness, B.; Cohen, R. B.; Langer, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies
    Meeting Abstract

    Mitsiades, N.; Schultz, N.; Taylor, B. S.; Hieronymus, H.; Satagopan, J.; Scardino, P. T.; Reuter, V. E.; Sander, C.; Sawyers, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Locally advanced prostate cancer: A population-based study of treatment patterns and predictors
    Meeting Abstract

    Lowrance, W.; Eastham, J.; Jacks, L.; Yee, D.; Scardino, P.; Elkin, E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Association between immune-related adverse events (irAEs) and disease control or overall survival in patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials
    Meeting Abstract

    Lutzky, J.; Wolchok, J.; Hamid, O.; Lebbe, C.; Pehamberger, H.; Linette, G.; de Pril, V.; Ibrahim, R.; Hoos, A.; O'Day, S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save